Literature DB >> 19799863

Eto2/MTG16 and MTGR1 are heteromeric corepressors of the TAL1/SCL transcription factor in murine erythroid progenitors.

Ying Cai1, Zhixiong Xu, Jingping Xie, Amy-Joan L Ham, Mark J Koury, Scott W Hiebert, Stephen J Brandt.   

Abstract

The TAL1 (or SCL) gene, originally discovered through its involvement by a chromosomal translocation in T-cell acute lymphoblastic leukemia, encodes a basic helix-loop-helix (bHLH) transcription factor essential for hematopoietic and vascular development. To identify its interaction partners, we expressed a tandem epitope-tagged protein in murine erythroleukemia (MEL) cells and characterized affinity-purified Tal1-containing complexes by liquid chromatography-tandem mass spectrometry analysis. In addition to known interacting proteins, two proteins related to the Eight-Twenty-One (ETO) corepressor, Eto2/Mtg16 and Mtgr1, were identified from the peptide fragments analyzed. Tal1 interaction with Eto2 and Mtgr1 was verified by coimmunoprecipitation analysis in Tal1, Eto2-, and Mtgr1-transfected COS-7 cells, MEL cells expressing V5 epitope-tagged Tal1 protein, and non-transfected MEL cells. Mapping analysis with Gal4 fusion proteins demonstrated a requirement for the bHLH domain of Tal1 and TAF110 domain of Eto2 for their interaction, and transient transfection and glutathione S-transferase pull-down analysis showed that Mtgr1 and Eto2 enhanced the other's association with Tal1. Enforced expression of Eto2 in differentiating MEL cells inhibited the promoter of the Protein 4.2 (P4.2) gene, a direct target of TAL1 in erythroid progenitors, and transduction of Eto2 and Mtgr1 augmented Tal1-mediated gene repression. Finally, chromatin immunoprecipitation analysis revealed that Eto2 occupancy of the P4.2 promoter in MEL cells decreased with differentiation, in parallel with a decline in Eto2 protein abundance. These results identify Eto2 and Mtgr1 as authentic interaction partners of Tal1 and suggest they act as heteromeric corepressors of this bHLH transcription factor during erythroid differentiation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19799863      PMCID: PMC2774815          DOI: 10.1016/j.bbrc.2009.09.111

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  34 in total

1.  Vectors and gene targeting modules for tandem affinity purification in Schizosaccharomyces pombe.

Authors:  J J Tasto; R H Carnahan; W H McDonald; K L Gould
Journal:  Yeast       Date:  2001-05       Impact factor: 3.239

Review 2.  E protein function in lymphocyte development.

Authors:  Melanie W Quong; William J Romanow; Cornelis Murre
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

3.  Deletion of Mtg16, a target of t(16;21), alters hematopoietic progenitor cell proliferation and lineage allocation.

Authors:  Brenda J Chyla; Isabel Moreno-Miralles; Melissa A Steapleton; Mary Ann Thompson; Srividya Bhaskara; Michael Engel; Scott W Hiebert
Journal:  Mol Cell Biol       Date:  2008-08-18       Impact factor: 4.272

4.  mSin3A regulates murine erythroleukemia cell differentiation through association with the TAL1 (or SCL) transcription factor.

Authors:  S Huang; S J Brandt
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

5.  P/CAF-mediated acetylation regulates the function of the basic helix-loop-helix transcription factor TAL1/SCL.

Authors:  S Huang; Y Qiu; Y Shi; Z Xu; S J Brandt
Journal:  EMBO J       Date:  2000-12-15       Impact factor: 11.598

6.  The transcriptional corepressor MTG16a contains a novel nucleolar targeting sequence deranged in t (16; 21)-positive myeloid malignancies.

Authors:  André T Hoogeveen; Stefano Rossetti; Violeta Stoyanova; Joris Schonkeren; Angelia Fenaroli; Luisa Schiaffonati; Leontine van Unen; Nicoletta Sacchi
Journal:  Oncogene       Date:  2002-09-26       Impact factor: 9.867

7.  E protein silencing by the leukemogenic AML1-ETO fusion protein.

Authors:  Jinsong Zhang; Markus Kalkum; Soichiro Yamamura; Brian T Chait; Robert G Roeder
Journal:  Science       Date:  2004-08-27       Impact factor: 47.728

Review 8.  The ETO (MTG8) gene family.

Authors:  J Nathan Davis; Laura McGhee; Shari Meyers
Journal:  Gene       Date:  2003-01-16       Impact factor: 3.688

9.  SCL assembles a multifactorial complex that determines glycophorin A expression.

Authors:  Rachid Lahlil; Eric Lécuyer; Sabine Herblot; Trang Hoang
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

10.  Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma.

Authors:  L R Finger; J Kagan; G Christopher; J Kurtzberg; M S Hershfield; P C Nowell; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

View more
  19 in total

Review 1.  Off to a Bad Start: Cancer Initiation by Pluripotency Regulator PRDM14.

Authors:  Lauren J Tracey; Monica J Justice
Journal:  Trends Genet       Date:  2019-05-23       Impact factor: 11.639

Review 2.  Role of helix-loop-helix proteins during differentiation of erythroid cells.

Authors:  Archana Anantharaman; I-Ju Lin; Joeva Barrow; Shermi Y Liang; Jude Masannat; John Strouboulis; Suming Huang; Jörg Bungert
Journal:  Mol Cell Biol       Date:  2011-01-31       Impact factor: 4.272

3.  Dynamic interaction between TAL1 oncoprotein and LSD1 regulates TAL1 function in hematopoiesis and leukemogenesis.

Authors:  Y Li; C Deng; X Hu; B Patel; X Fu; Y Qiu; M Brand; K Zhao; S Huang
Journal:  Oncogene       Date:  2012-02-06       Impact factor: 9.867

Review 4.  KDM1 class flavin-dependent protein lysine demethylases.

Authors:  Jonathan M Burg; Jennifer E Link; Brittany S Morgan; Frederick J Heller; Amanda E Hargrove; Dewey G McCafferty
Journal:  Biopolymers       Date:  2015-07       Impact factor: 2.505

5.  Myeloid translocation gene 16 is required for maintenance of haematopoietic stem cell quiescence.

Authors:  Melissa A Fischer; Isabel Moreno-Miralles; Aubrey Hunt; Brenda J Chyla; Scott W Hiebert
Journal:  EMBO J       Date:  2012-01-20       Impact factor: 11.598

6.  Myeloid translocation gene CBFA2T3 directs a relapse gene program and determines patient-specific outcomes in AML.

Authors:  Nickolas Steinauer; Chun Guo; Chunfa Huang; Madeline Wong; Yifan Tu; Carl E Freter; Jinsong Zhang
Journal:  Blood Adv       Date:  2019-05-14

7.  Enforced expression of E47 has differential effects on Lmo2-induced T-cell leukemias.

Authors:  Charnise Goodings; Rati Tripathi; Susan M Cleveland; Natalina Elliott; Yan Guo; Yu Shyr; Utpal P Davé
Journal:  Leuk Res       Date:  2014-11-29       Impact factor: 3.156

8.  RUNX1 represses the erythroid gene expression program during megakaryocytic differentiation.

Authors:  Olga N Kuvardina; Julia Herglotz; Stephan Kolodziej; Nicole Kohrs; Stefanie Herkt; Bartosch Wojcik; Thomas Oellerich; Jasmin Corso; Kira Behrens; Ashok Kumar; Helge Hussong; Henning Urlaub; Joachim Koch; Hubert Serve; Halvard Bonig; Carol Stocking; Michael A Rieger; Jörn Lausen
Journal:  Blood       Date:  2015-04-24       Impact factor: 22.113

9.  LMO2 Oncoprotein Stability in T-Cell Leukemia Requires Direct LDB1 Binding.

Authors:  Justin H Layer; Catherine E Alford; W Hayes McDonald; Utpal P Davé
Journal:  Mol Cell Biol       Date:  2015-11-23       Impact factor: 4.272

10.  Lmo2 induces hematopoietic stem cell-like features in T-cell progenitor cells prior to leukemia.

Authors:  Susan M Cleveland; Stephen Smith; Rati Tripathi; Elizabeth M Mathias; Charnise Goodings; Natalina Elliott; Dunfa Peng; Wael El-Rifai; Dajun Yi; Xi Chen; Liqi Li; Charles Mullighan; James R Downing; Paul Love; Utpal P Davé
Journal:  Stem Cells       Date:  2013-05       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.